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Abstract
Background: Total ankle arthroplasty (TAA) has become increasingly popular worldwide as an alternative to ankle
arthrodesis for surgical treatment of end-stage ankle arthritis. The aim of this epidemiological study, using a
national inpatient database in Japan, was to describe the volume, utilization, patient characteristics, and temporal
trends regarding these procedures in Japan, and to identify the risk factors associated with perioperative adverse
events in TAA.
Methods: This was a population-based, retrospective cohort study. We retrospectively identified 2775 patients in
the Diagnosis Procedure Combination database who underwent ankle arthrodesis or TAA for ankle arthritis at 559
hospitals in Japan from 2007 to 2013. Information on sex, age, main diagnosis, use of blood transfusion, duration of
anesthesia, length of hospital stay, in-hospital mortality, hospitalization costs, additional procedures after primary
surgery, and use of negative pressure wound therapy was extracted. Multivariable logistic regression analysis was
performed to analyze the effect of various factors on the incidence of perioperative adverse events in TAA, including
additional procedure during hospitalization, negative pressure wound therapy, blood transfusion, and in-hospital death.
Results: We identified 465 patients who underwent TAA and 2310 patients who underwent ankle arthrodesis. There
was no apparent increase in the proportion of TAAs performed during the survey period. Patients undergoing TAA
tended to be older, female, and have rheumatoid arthritis compared with those undergoing ankle arthrodesis. Patients
undergoing TAA had shorter length of stay, higher hospitalization costs, and more blood transfusions compared with
those undergoing ankle arthrodesis. Lower hospital volume and shorter anesthesia time were associated with higher
rates of adverse events after TAA.
Conclusions: Despite an increase in the popularity of TAA internationally, the number of TAAs performed remains low
in Japan. Lower hospital volume and anesthesia time were associated with higher rates of perioperative adverse events
after TAA.
Level of evidence: IV, Cross-sectional study
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Background
Forty years have passed since the introduction of the
first-generation total ankle arthroplasty (TAA), which
ended in failure because of high rates of aseptic loosen-
ing and pain. Refinement of implant design by adoption
of mobile bearings and technological advances has grad-
ually improved the clinical outcomes after TAA. A re-
cent systematic review of recent TAA studies, reported
an overall survivorship of 89 % at 10 years [1]. Based on
improved clinical outcomes, TAA has become increas-
ingly popular as an alternative to arthrodesis, which has
long been the gold standard for treating end-stage ankle
arthritis. A previous report using the United States Na-
tionwide Inpatient Sample data contained data from five
to eight million hospital stays and discharges from >
1,000 hospitals sampled to approximate a 20 % stratified
sample of United States community hospitals. This sam-
ple showed an approximately 6-fold increase in TAA
utilization in the previous decade, from 0.13 per 100,000
population in 1998 to 0.84 per 100,000 population in
2010 [2]. Another study from the United States using
the Medicare database included 5871 patients who
underwent TAA and 29532 patients who underwent
ankle arthrodesis between 1991 and 2010; this study re-
ported an increase in TAA volume from 72 procedures
in 1991 to 888 in 2010 [3]. The study also revealed that
the percentage of all United States hospitals performing
TAA increased by approximately 4-fold from 3.1 % in
1991 to 12.6 % in 2010, while the proportion performing
ankle arthrodesis remained unchanged. Although the
sample sizes were smaller than those in the United
States studies, joint registry data from northern Euro-
pean nations also showed a more than 2-fold increase in
TAA in a recent decade [4, 5]. Joint registry data from
New Zealand demonstrated an approximately 4-fold in-
crease in TAA from 26 arthroplasties in 2003 to 113
arthroplasties in 2013 [6].
Because there is a steep learning curve for the TAA
procedure [7–11], improved outcomes and decreased
complications would be expected by virtue of the global
growth in the number of procedures performed [12]. Al-
though there has been an increase in the number of
TAA procedures performed around the world, TAA is
still considered a fairly rare procedure in Japan. There
have been no published studies revealing epidemiological
data on TAA utilization within Japan.
Although TAA has been recently popularized world-
wide, it is still accompanied by higher rates of compli-
cations compared with total hip and knee arthroplasties
[1, 13–15]. Surgeon understanding of the complications
and their risk factors is important to provide good clin-
ical outcomes; however, there is limited evidence avail-
able in the literature about risk factors for perioperative
complications after TAA.
The purpose of this study was (i) to assess recent
trends in the use of TAA compared with ankle arthrod-
esis in Japan, and (ii) to identify the risk factors associ-
ated with perioperative complications in TAA using the
Diagnosis Procedure Combination (DPC) database, a
large national inpatient database in Japan.
Methods
Data source
The DPC database is a national administrative claims
and discharge database on acute-care inpatients in Japan.
All 82 academic hospitals in Japan are obliged to adopt
this system, while community hospitals participate on a
voluntary basis. The numbers of participating hospitals
were 898, 855, 901, 980, 1,075, 1,057, and 1,061, in fiscal
years 2007, 2008, 2009, 2010, 2011, 2012, and 2013, re-
spectively. Data were collected during 6 months (from
July 1 to December 31) between fiscal years 2007 and
2009, 9 months (from July 1 to March 31) in fiscal year
2010, and throughout the year (from April 1 to March
31) from fiscal year 2011 on. The numbers of admissions
in the database were 2.65, 2.81, 2.78, 4.95, 7.14, 6.85, and
7.11 million in fiscal years 2007, 2008, 2009, 2010, 2011,
2012, and 2013, respectively. The number in 2013 repre-
sented approximately 50 % of all inpatient admissions to
acute-care hospitals in Japan.
The DPC database includes the following: age and sex;
diagnoses, comorbidities at admission, and complica-
tions after admission recorded with text data in the
Japanese language and the International Classification
of Diseases, Tenth Revision (ICD-10) codes; procedures
coded using the Japanese original codes; duration of
anesthesia; drugs and implants used; blood transfusion;
length of hospital stay; in-hospital mortality; and
hospitalization costs.
Data extraction
Data were retrospectively collected on patients who re-
ceived either primary TAA or ankle arthrodesis between
2007 and 2013. Patients who had a fracture from a traf-
fic accident, pyogenic arthritis, Charcot disease, diabetic
arthritis, or pigmented villonodular synovitis were ex-
cluded to focus on patients with ankle arthritis due to in-
flammatory pathology and osteoarthritis. Eligible patients
were divided into osteoarthritis (OA) and rheumatoid
arthritis (RA) groups. The outcomes included length of
hospital stay (days), hospitalization costs, operative costs,
use of blood transfusion, in-hospital mortality, additional
procedures during hospitalization after primary surgery,
and use of negative pressure wound therapy. Details of
additional procedures were further divided into the fol-
lowing categories: wound treatment, skin graft of flap,
and limb amputation. Perioperative adverse events were
defined as the composite outcome, including additional
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procedure during hospitalization, negative pressure
wound therapy, blood transfusion, and in-hospital death.
Based on the protocol by Quan et al. [16], each ICD-
10 code of a comorbidity was converted to a score, and
the sum of the scores, excluding the score for RA (=1),
was used to calculate the patient’s Charlson Comorbidity
Index [17]. Hospital volume was defined as the mean
number of TAAs performed per year at each institution.
Patients were dichotomized into low-volume (≤ 4 cases/
year) and high-volume (≥ 5 cases/year) groups according
to the only previous study reporting the influence of
hospital volume on complications after TAA [18]. For
analysis of hospitalization costs, 1 US dollar was assumed
to be 100 Japanese yen.
Statistical analysis
We performed univariate comparisons of explanatory
variables using the chi-square test or analysis of vari-
ance, as appropriate. Multivariable linear regression or
multivariable logistic regression analyses were performed
for the comparison of outcomes between TAA and ankle
arthrodesis to adjust for the differences in demographics.
Multivariable logistic regression analysis was performed
to compare the independent factors associated with peri-
operative adverse events after TAA, with adjustment for
other variables. All demographic variables with a P-value
less than 0.1 in the univariate analyses were entered into
the multivariable logistic regression model. A P-value
less than 0.05 was considered statistically significant, and
Bonferroni adjustments were used to reduce the poten-
tial for false positives due to multiple comparisons. All
statistical analyses were performed using SPSS version
19.0 (IBM Corp., Armonk, NY, USA).
Results
We identified 465 patients who underwent TAA and
2,310 patients who underwent ankle arthrodesis at 559
hospitals during the survey period. The absolute num-
bers and proportions of these two procedures in each
year are shown in Table 1. The proportion of TAAs fluc-
tuated between 12 and 20 %.
Table 2 shows the patient backgrounds. The mean age
and the proportion of female patients were significantly
higher in the group who underwent TAA (69.1 years;
83.7 %) compared with those who underwent ankle arth-
rodesis (64.5 years; 70.7 %). The average age was signifi-
cantly higher in the TAA group than the ankle
arthrodesis group among OA patients, but was not sig-
nificantly different among RA patients. Patients with
TAA were more likely to have RA (38.5 vs 24.0 %).
There was no significant difference in anesthesia time
between the two groups.
The TAA group had a significantly shorter average
hospital stay compared with the ankle arthrodesis group,
and total hospitalization costs and operative costs were
significantly higher in the TAA group compared with
the ankle arthrodesis group (Table 3); the differences in
these variables were also significant after adjusting the
differences in demographics (Table 3A, B). There were
no significant differences in the performance of an add-
itional procedure during hospitalization or in the use of
negative pressure wound therapy between the ankle
arthrodesis and TAA groups, and the differences were
also not significant after adjusting for the differences in
demographics (Table 3A, B). The proportion of patients
receiving a blood transfusion was significantly higher in
the TAA group than in the ankle arthrodesis group, al-
though this difference was not significant after adjusting
for the differences in demographics (Table 3A, B).
Table 4 shows the incidence of perioperative adverse
events limited to the patients who underwent TAA. The
overall rate of perioperative adverse events during
hospitalization was 7.1 % (33 of 465). The rate of peri-
operative adverse events was higher in those with a
Charlson Comorbidity Index of 1 or greater, those in the
low-volume hospital group, and those with anesthesia
time of 200 min or greater. Multivariable logistic regres-
sion analysis demonstrated that perioperative adverse
events after TAA were independently associated with
hospital volume and anesthesia time, with significantly
reduced odds in high-volume hospitals (odds ratio, 0.31;
95 % confidence interval, 0.10–0.96; Table 5) and
Table 1 Numbers of patients and hospitals undergoing ankle arthrodesis or total ankle arthroplasty
Year 2007 2008 2009 2010 2011 2012 2013 Total
Ankle arthrodesis 152 (80.4 %) 223 (87.5 %) 183 (85.1 %) 293 (88.3 %) 440 (82.4 %) 524 (82.1 %) 495 (80.9 %) 2310 (83.2 %)
Total ankle arthroplasty 37 (19.6 %) 32 (12.5 %) 32 (14.9 %) 39 (11.7 %) 94 (17.6 %) 114 (17.9 %) 117 (19.1 %) 465 (16.8 %)
Total 189 255 215 332 534 638 612 2775
Data collection periods
(months)
6 6 6 9 12 12 12 —
Number of enrolled
hospitals in DPC
898 855 901 980 1075 1057 1061 —
Number of admissions
in DPC (million)
2.65 2.81 2.78 4.95 7.14 6.85 7.11 34.29
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Table 2 Comparison of patient characteristics and anesthesia time between ankle arthrodesis and total ankle arthroplasty groups
Total (n = 2775) Ankle arthrodesis (n = 2310) Total ankle arthroplasty (n = 465) P-value
Age (years), mean ± SD 65.7 ± 11.2 64.5 ± 11.4 69.1 ± 9.2 < 0.001
in osteoarthritis patients 66.3 ± 11.6 65.4 ± 11.8 72.1 ± 8.3 < 0.001
in rheumatoid arthritis patients 63.9 ± 9.9 63.8 ± 10.2 64.4 ± 8.6 0.452
Sex (female) 2022 (72.9 %) 1633 (70.7 %) 389 (83.7 %) < 0.001
Body mass index (kg/m2), mean ± SD 24.4 ± 3.9 24.5 ± 4.0 24.2 ± 3.7 0.328
Smoking
Nonsmoker 1931 (69.6 %) 1590 (68.8 %) 341 (73.3 %) 0.043
Ex or current smoker 323 (11.6 %) 284 (12.3 %) 39 (8.4 %)
Missing 521 (18.8 %) 436 (18.9 %) 85 (18.3 %)
Underlying diagnosis
Osteoarthritis 2042 (73.6 %) 1756 (76.0 %) 286 (61.5 %) < 0.001
Rheumatoid arthritis 733 (26.4 %) 554 (24.0 %) 179 (38.5 %)
Charlson Comorbidity Index
0 2472 (89.0 %) 2049 (88.7 %) 423 (91.0 %) 0.153
≥ 1 303 (11.0 %) 261 (11.3 %) 42 (9.0 %)
Anesthesia time (minutes), mean ± SD 199 ± 91 199 ± 93 200 ± 84 0.127
The values in bold indicate significant differences at the 0.007 (=0.05/7) significance level
Table 3 Comparison of perioperative outcomes between ankle arthrodesis and total ankle arthroplasty groups (A), and adjusted
coefficient of determination and odds ratio of major outcomes in total ankle arthroplasty group using ankle arthrodesis group as a
control (B)
A.
Total (n = 2775) Ankle arthrodesis (n = 2310) Total ankle arthroplasty (n = 465) P-value
Length of stay (days), mean ± SD 41.8 ± 28.2 42.8 ± 29.1 36.9 ± 23.6 < 0.001a
Hospitalization costs (dollars), mean ± SD 16111 ± 8002 15123 ± 8085 21019 ± 7595 < 0.001a
Costs of operation (dollars), mean ± SD 6196 ± 2635 5063 ± 2576 11827 ± 2927 < 0.001a
Additional procedure during hospitalization 90 (3.2 %) 76 (3.3 %) 14 (3.0 %) 0.756
Wound treatment 68 (2.5 %) 54 (2.3 %) 14 (3.0 %) 0.392
Skin graft or flap 18 (0.6 %) 16 (0.7 %) 2 (0.4 %) 0.520
Limb amputation 1 (0.04 %) 1 (0.04 %) 0 (0.00 %) 0.654
Negative pressure wound therapy 8 (0.3 %) 6 (0.3 %) 2 (0.4 %) 0.525
Blood transfusion (number of patients) 85 (3.1 %) 61 (2.6 %) 24 (5.2 %) 0.004a
In-hospital death 2 (0.07 %) 2 (0.09 %) 0 (0.00 %) 0.999
B.
Coefficient 95 % CI P-value
Length of stay (days) −6.9 −10.0 to -3.7 < 0.001b
Hospitalization costs (dollars) 5531 4647–6417 < 0.001b
Costs of operation (dollars) 6577 6274–6881 < 0.001b
Odds ratio 95 % CI P-value
Additional procedure during hospitalization 0.85 0.43–1.68 0.634
Blood transfusion (number of patients) 1.40 0.77–2.53 0.270
aThe values in bold indicate significant differences at the 0.005 (=0.05/10) significance level
bThe values in bold indicate significant differences at the 0.05 significance level
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significantly increased odds in the group with longer
anesthesia time (odds ratio, 2.83; 95 % confidence interval,
1.10–7.28; Table 5).
Discussion
Evidence of improved clinical outcomes has resulted in
an increase in the number of TAAs performed world-
wide for end-stage ankle arthritis. The present study
found that TAA remains a less common procedure in
Japan, and that low hospital volume was associated with
an increased risk of complications after TAA.
The proportion of TAAs performed did not show any
apparent increase between 2007 and 2013 in Japan, and
only around 100 TAAs were performed annually after
2011. Considering the fact that the DPC database covers
more than 50 % of all inpatient admissions to acute-care
hospitals in Japan, it can be estimated that 0.2 TAA per
100,000 inhabitants is performed annually in Japan. This
figure is fairly low compared with 1 TAA per 100,000 in-
habitants in Sweden, Norway, and the United Kingdom
[4, 5, 19], approximately 2 per 100,000 inhabitants in
Finland and Germany [13, 20], 0.6 to 2.5 per 100,000 in-
habitants in Australia and New Zealand [6, 21], and 1.9 to
4.0 per 100,000 inhabitants in the United States [3, 22].
The ratio of TAA to ankle arthrodesis was also low in the
present study (1:6), compared with 1:2–3 in the United
States, France, and Germany [3, 18, 20, 23]. These differ-
ences likely reflect preferences of surgeons in Japan to per-
form ankle arthrodesis over TAA compared with surgeons
in Western countries.
The present study showed that the underlying diagno-
sis was significantly different between TAA and ankle
arthrodesis groups, indicating the preference of surgeons
to perform TAA over ankle arthrodesis for patients with
RA in Japan. The percentage of RA as an underlying
diagnosis among patients undergoing TAA was 38.5 %
in the present study, which was comparable to that in
Scandinavian countries [4, 5, 13]. In contrast, studies
from Australia, New Zealand, the United Kingdom,
France, and the United States demonstrated that the per-
centage of RA was less than or around 10 % [6, 19, 21,
24]. A previous study from the United States demon-
strated a decrease in the percentage of RA from 10.8 %
in 1998–2000 to 4.9 % in 2009–2010 [2]. This trend
could indicate that growing evidence of good clinical
Table 4 Incidence of perioperative adverse events after total
ankle arthroplasty in each subgroup
Total Perioperative adverse events P-value
All 465 33 (7.1 %)
Age (year) 0.071
≤ 39 4 1 (25.0 %)
40–49 6 1 (16.7 %)
50–59 56 8 (14.3 %)
60–69 152 12 (7.9 %)
70–79 197 8 (4.1 %)
≥ 80 50 3 (6.0 %)
Sex
Male 76 6 (7.9 %) 0.767
Female 389 27 (6.9 %)
Body mass index
< 30 333 22 (6.6 %) 0.857
≥ 30 26 3 (11.5 %)
Missing 106 8 (7.5 %)
Smoking
Nonsmoker 322 19 (6.0 %) 0.128
Ex or current smoker 35 4 (11.4 %)
Missing 75 10 (13.3 %)
Charlson Comorbidity Index
0 423 26 (6.1 %) 0.001
≥ 1 42 7 (16.7 %)
Mean hospital volume (per year)
≤ 4 269 29 (10.8 %) < 0.001
≥ 5 196 4 (2.0 %)
Underlying diagnosis
Osteoarthritis 286 13 (4.5 %) 0.007
Rheumatoid arthritis 179 20 (11.2 %)
Anesthesia time
< 200 min 270 7 (2.6 %) < 0.001
≥ 200 min 195 26 (13.3 %)
The values in bold indicate significant differences at the 0.006 (=0.05/8)
significance level
Table 5 Multivariable logistic regression for perioperative
adverse events after total ankle arthroplasty
Odds ratio 95 % CI P-value
Age (years) 0.970 0.932–1.010 0.140
Charlson Comorbidity Index
0 1.00
≥ 1 2.16 0.83–5.64 0.116
Mean hospital volume (per year)
≤ 4 1.00
≥ 5 0.31 0.10–0.96 0.042
Underlying diagnosis
Osteoarthritis 1.00
Rheumatoid arthritis 1.43 0.63–3.24 0.393
Anesthesia time
< 200 min 1.00
≥ 200 min 2.83 1.10–7.28 0.031
The values in bold indicate significant differences at the 0.05 significance level
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outcomes after TAA has been expanding the indication
for TAA from low-activity patients such as those with
RA to higher-level activity patients. The higher percent-
age of TAA utilization in RA patients in Japan may
imply that Japanese surgeons have a perception that the
risks outweigh the benefits in high-activity patients and
the benefits outweigh the risks in those with RA.
Both the total hospitalization costs and operative costs
were significantly higher in the TAA group. This can be
explained by the high implant costs associated with
arthroplasty. The blood transfusion rate was significantly
lower in the ankle arthrodesis group. This result is
contradictory to a report that compared the periopera-
tive complications and hospitalization outcomes after
ankle arthrodesis and TAA using the data of the Na-
tional Inpatient Sample in the United States, which has
been the only study comparing the blood transfusion
rate between the two groups [23]. We could not perform
a multivariate analysis to adjust for differences in demo-
graphics and comorbidities according to blood transfu-
sion because of the small number of events. Further
accumulation of data will be needed to make a conclu-
sion about this topic.
There are a limited number of studies comparing the
perioperative complications and hospitalization out-
comes between ankle arthrodesis and TAA. A previous
study in the United States reported that TAA was inde-
pendently associated with a decreased risk of overall
complication during hospitalization [23]. Another study
in the United States reported that patients treated with
TAA had a significantly increased rate of major revision
at 90 days postoperatively [25]. A multicenter, prospect-
ive, cohort study by the Canadian Orthopaedic Foot and
Ankle Society comparing ankle arthrodesis and TAAs
performed between 2001 and 2007 reported that the
major complication rate was 7 % for ankle arthrodesis
and 19 % for TAA [26]. Because of the difference in ob-
servational periods, definition of complications, and
backgrounds of the patients, we could not directly com-
pare the present study with previous ones. In particular,
the duration of hospitalization in Japan is the longest
among the Organisation for Economic Co-operation and
Development countries [27], which might be attributed
to factors including differences in healthcare systems
and cultural norms. The duration of hospitalization of
around 40 days after TAA in Japan (including the re-
habilitation period) is far longer than that, for example,
in the US, which is reportedly around 3 days [3, 22].
Owing to the longer duration of hospitalization in Japan,
we consider that most of the perioperative complications
were included in our analysis. We believe the present
study is valuable in revealing that most of the additional
procedures during hospitalization were related to wound
complications and there was no significant difference in
the rate of additional procedures required for these be-
tween TAA and ankle arthrodesis groups.
Wound issues are one of the common complications
in both TAA and ankle arthrodesis, and can be a major
problem, leading to implant infection and limb amputa-
tion especially after TAA [28]. A multicenter, prospective,
nonrandomized, 2-phase comparison of ankle arthrodesis
and Scandinavian Total Ankle Replacement (STAR)
showed that major complications and the need for sec-
ondary surgical intervention were more common in the
TAA group; however, the rate of major complications in
the TAA group decreased in the second phase of the trial
compared with the first phase [12], and this was attributed
to increased surgeon experience and some modifications
to the instruments and technique. As that study demon-
strated, the rate of perioperative complications after TAAs
procedure is also associated with the popularization of
TAA. We believe that the present study provides import-
ant epidemiological information for future investigations.
Many factors have been considered risks for delayed
wound healing in total joint arthroplasty, including pre-
vious incisions, lymphedema, poor vascular perfusion,
obesity, diabetes mellitus, inflammatory arthropathy,
renal or liver disease, immune compromise, corticoster-
oid therapy, smoking, poor nutrition, and a long opera-
tive time [29–31]; some of these have also been
identified as risks in TAA. Raikin et al. reported that
underlying inflammatory arthritis was the only signifi-
cant risk factor for major wound complications using
multivariate analysis [32]; however, RA was not identi-
fied as an independent risk factor in the present study.
Because background and indication for surgeries in RA
patients might differ between countries, direct comparison
is difficult. Obesity and smoking are well-recognized risk
factors for delayed wound healing after TAA [33–36], al-
though these factors were not identified as risks in the
present study. We think that this inconsistency might be
attributed to the small number of subjects in the present
study. Kessler et al. reported that patients with wound
healing problems were at risk for infection of TAA, and
patients with periprosthetic ankle joint infection had lon-
ger operative times than matched controls [28]. The
present study demonstrated that longer anesthesia time
was independently associated with perioperative compli-
cations. We could not obtain the operative time from the
DPC database, and so we substituted anesthesia time as a
reflection of the operative time.
Some studies suggested that low-volume centers were
associated with implant failures or poor survival rate
[18, 37]. In France, the National Commission for the
Evaluation of Medical Devices and Healthcare Technolo-
gies proposed to limit TAA to centers that performed at
least 10 TAAs per year for the past 3 years [18]. The
present study demonstrated that a higher hospital
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volume was independently associated with a lower rate
of perioperative complications after TAA. A study from
France, which has been the only study analyzing the ef-
fect of hospital volume on outcome after TAA, reported
that infectious and cutaneous complications were more
likely to occur in high-volume centers (≥ 5 cases/year)
compared with the low-volume centers (≤ 4 cases/year)
(16 % vs 5 %, P = 0.015) [18]. They included only 97
cases performed in 3 high-volume centers and 86 cases
in 6 low-volume centers. We believe our study is ad-
vantageous because of its large sample from a national
database. Given the technical demands and experience
required to perform TAA successfully, the current situ-
ation in Japan that most hospitals perform < 5 TAAs
annually raises concerns about provider competence.
Moreover, the dispersion of a relatively low number of
TAA cases over many hospitals may make the investi-
gation of clinical outcomes difficult, and may be one of
the reasons for the slow growth of TAA in Japan. An-
other possible reason for the slow growth of TAA is the
limited availability of marketed TAA designs. Only 2
implants are available in Japan: the TNK ankle (Kyocera
Medical, Osaka, Japan) and the FINE total ankle system
(Teijin Nakashima Medical, Okayama, Japan). The
numbers of different implant designs available in other
countries are 10 in Australia, 7 in the UK, 6 in the
United States, New Zealand, and Sweden, and 5 in
Finland and Norway [38]. In addition, we have demon-
strated that the lower the number of TAA cases per
hospital, the more susceptible the TAA procedure is to
complications. This may make it more difficult for sur-
geons to opt for TAA. To make it possible for the public
to access this therapeutic option, further efforts will be re-
quired by Japanese foot and ankle surgeons to investigate
the long-term clinical outcomes of Japan-originated TAA
implants. A joint registry system or centralization of TAA
cases at a restricted number of facilities should be consid-
ered as one means for solving the problem. Moreover,
creating opportunities to obtain additional specialized
training for surgeons aiming to perform TAA would be
desirable to compensate for this lack of experience.
Several limitations of our study must be acknowl-
edged. First, the use of an administrative claims database
could have led to underestimation or overestimation of
backgrounds or perioperative complications because of
incomplete reporting or misclassification. Although we
were unable to verify the data for each patient, we pre-
sume that there was no difference in the proportion of
miscoding between the TAA and ankle arthrodesis
groups, and that the level of miscoding is low if any, as
the DPC data are coded by physicians and subject to an
audit. Second, the DPC database is less likely to reflect
the situation in small hospitals because hospitals partici-
pating in the database are relatively large. Third, the
DPC data was not obtained for the entire year between
2007 and 2010. However, we believe that there may not
be any selection bias, as there is presumably no seasonal
variation in the surgical procedures evaluated in this
study. Fourth, although surgeon volume might also
affect the perioperative complications, this information
was not able to be obtained and included in the analyses.
However, most of the perioperative complications were
assumed to be included in our analysis as the mean hos-
pital stay was around 40 days in both groups. Despite
these limitations, we believe that the present study is
epidemiologically important because it demonstrates
trends in the use of ankle arthrodesis/TAA and com-
pared backgrounds and perioperative complications
comprehensively between these two procedures for the
first time in the Japanese population.
Conclusions
In summary, the proportion of TAA procedures did not
markedly increase from 2007 to 2013 in Japan, in con-
trast to an increase reported in other developed coun-
tries. Lower hospital volume and anesthesia time were
associated with higher rates of perioperative adverse
events after TAA.
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